India Proposes Foreign Pharma Buyers Make Five-Year R&D Commitment
This article was originally published in PharmAsia News
Executive Summary
India authorities are considering a requirement that foreign investors in its pharmaceutical industry continue to conduct research and development and produce essential drugs for at least five years after making an acquisition.